{"id":48336,"date":"2022-09-13T23:02:15","date_gmt":"2022-09-13T21:02:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/"},"modified":"2022-09-13T23:02:15","modified_gmt":"2022-09-13T21:02:15","slug":"johnson-johnson-to-host-investor-conference-call-on-third-quarter-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/","title":{"rendered":"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results"},"content":{"rendered":"<div>\n<p>NEW BRUNSWICK, N.J.&#8211;(BUSINESS WIRE)&#8211;Johnson &amp; Johnson (NYSE: JNJ) will host a conference call for investors at <b>8:30 a.m. (Eastern Time) on Tuesday, October 18<sup>th<\/sup>, 2022, <\/b>to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson &amp; Johnson\u2019s executive team.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/5\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\"><\/a><\/p>\n<p>\nInvestors and other interested parties can access the webcast\/conference call in the following ways:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nThe webcast and presentation material are accessible at Johnson &amp; Johnson\u2019s website <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.investor.jnj.com&amp;esheet=52891086&amp;newsitemid=20220913005979&amp;lan=en-US&amp;anchor=www.investor.jnj.com&amp;index=1&amp;md5=9c11940cf775bd89057c2448d7593e94\" rel=\"nofollow noopener\" shape=\"rect\">www.investor.jnj.com<\/a>. A replay of the webcast will be available approximately three hours after the conference call concludes.\n<\/li>\n<li>\nBy telephone: for both \u201clisten-only\u201d participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.\n<\/li>\n<li>\nA replay of the conference call will be available until approximately 12:00 a.m. on November 1<sup>st<\/sup>. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13732673.\n<\/li>\n<li>\nThe press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.\n<\/li>\n<li>\nPlease refer to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fjohnsonandjohnson.gcs-web.com%2Fevents-and-presentations&amp;esheet=52891086&amp;newsitemid=20220913005979&amp;lan=en-US&amp;anchor=www.investor.jnj.com&amp;index=2&amp;md5=1fc1c47284f6a26958195263d87ea4ed\" rel=\"nofollow noopener\" shape=\"rect\">www.investor.jnj.com<\/a> for a complete list of currently planned earnings webcast\/conference calls. Please note the fourth-quarter date of Tuesday, January 24<sup>th<\/sup>, 2023.\n<\/li>\n<\/ul>\n<p>\nAbout Johnson &amp; Johnson\n<\/p>\n<p>\nAt Johnson &amp; Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That\u2019s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world\u2019s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Press Contact:<\/b><br \/>Jake Sargent<br \/>\n<br \/>(732) 524-1090\n<\/p>\n<p>\n<b>Investor Contacts:<\/b><br \/>Jessica Moore<br \/>\n<br \/>(732) 524-2955\n<\/p>\n<p>\nSarah Wood<br \/>\n<br \/>(732) 524-2617\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW BRUNSWICK, N.J.&#8211;(BUSINESS WIRE)&#8211;Johnson &amp; Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48336","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW BRUNSWICK, N.J.&#8211;(BUSINESS WIRE)&#8211;Johnson &amp; Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-13T21:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results\",\"datePublished\":\"2022-09-13T21:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/\"},\"wordCount\":393,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913005979\\\/en\\\/1570226\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/\",\"name\":\"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913005979\\\/en\\\/1570226\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\",\"datePublished\":\"2022-09-13T21:02:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913005979\\\/en\\\/1570226\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913005979\\\/en\\\/1570226\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/","og_locale":"en_US","og_type":"article","og_title":"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results - Pharma Trend","og_description":"NEW BRUNSWICK, N.J.&#8211;(BUSINESS WIRE)&#8211;Johnson &amp; Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-13T21:02:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results","datePublished":"2022-09-13T21:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/"},"wordCount":393,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/","url":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/","name":"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","datePublished":"2022-09-13T21:02:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220913005979\/en\/1570226\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Johnson &amp; Johnson to Host Investor Conference Call on Third-Quarter Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48336"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48336\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}